As the UK PMCPA publishes its first social media guidance for pharmaceutical companies, what can they do to avoid traps when it comes to posting online?

The pharmaceutical industry is being urged to take action to bridge the access gap for women with gynaecological cancers, but what steps are needed to change the game?

Karen Pinachyan, Head of Medical Affairs for Europe, CSL Behring, talks to Isabel O’Brien about the power of personalised medicine, overhauling healthcare and why it is key to know your own mind

The Cannes Lions International Festival of Creativity is finished for another year, but how did the pharmaceutical industry perform?

This week (14-16 May) is National Women’s Health Week in the US. Read what the industry can do to close the gender health gap.

Lance Hill, CEO of Within3, talks to GOLD about the challenge of creating a market for their product and his personal and professional measures of success.

Marcel Gehrung, CEO and Co-Founder, Cyted, talks to Jade Williams about the greatest challenges facing his company.

GOLD talks to Stuart Peltz, CEO, PTC Therapeutics, about his company’s journey from a single lab to a multinational corporation.

Medical affairs must have its finger on the pulse of customer and patient preferences. Social listening is a key way for teams to keep up.

Sabine Hutchison, CEO, Seuss+, and Operating Board President, EMEA, The Healthcare Businesswomen’s Association, discusses the legislation, challenges and hopes for closing the pay gap in life sciences.

Pharma leader Emma Chaffin talks about leaving pharmacy for the pharma and a key challenge facing her function.

Synthetic data can streamline clinical trials and enable ideas to be tested without draining R&D budgets. Read more about pros and cons of this approach.

Explore the benefits of using agencies in pharma marketing and some of the reasons why creativity needs to be brought to the foreground.

Pharma is a popular destination for women entering the workforce, but how can the lack of representation at senior levels be addressed?

For pharma, building an ERG can be essential for inclusivity. Find out how to create a great one with these top tips.

Christi Shaw, former CEO, Kite Pharma, shares her thoughts on improving access to cell therapies and her motivations for working in oncology

Exploring the current state of the US pharmaceutical market, this article investigates the balance between innovation and access to care in the country.

Roche’s Davidek Herron offers his thoughts on the state of diversity, equity and inclusion in the pharma industry.

Despite continued advances in personalised medicine, there is still more to be done to encourage policy makers and payers to back these life-changing initiatives.

In 2021, the UK was named the sixth biggest pharmaceutical market, but it’s facing challenges to further growth. Read to find out more.

The future is brimming with possibilities for AI in healthcare, but eliminating bias is imperative, so where should pharma start?

AI holds buckets of potential for medical affairs teams, but it must be adopted considerately and correctly to meet their needs.

Pharma’s approach to customer experience could be improved with humanisation of digital touchpoints.

Novo Nordisk’s new obesity drug could be set to transform obesity care, but there’s much more that pharma can do to help.

GSK’s Judy Stewart discusses her ambition to work in pharmaceuticals and make a difference to public health, the vast GSK vaccine pipeline, leadership and the importance of work-life balance.

What are the generation differences in how HCPs want to talk to pharma? Three generations of doctors share their thoughts.

AstraZeneca’s Mina Makar talks about solving unmet needs and how to champion the patient perspective.

Many top pharma companies have cut their Twitter ad spend after the Eli Lilly scandal, but should they take a risk and return?

Roche’s Davidek Herron offers five top tips for pharma teams striving for omnichannel excellence.

How can pharma maximise the impact of key opinion leaders in the ever-evolving digital world?

Medical affairs is becoming increasingly complex, but industry-academia collaboration aims to tackle this head on.

The recent approval of lecanemab is a win for Alzheimer’s patients, but how can pharma ensure access?

Travel to Poland to discover the factors driving its pharmerging status and access to medicine challenges.

Explore the key trends and themes industry experts predict will be in store for pharma over the next 12 months.

Treatments for cancer are continuously advancing, but pharma must also focus on supporting patients’ mental health.

Pharma’s data lake is increasing in size. Read to find out how the industry can use it to its best advantage.

How can blockchain-based technology advance business development and investment?

5 minutes with Gen Li, President of clinical trial database company Phesi.

Pharma should double down on its patient centricity efforts to help tackle inequalities in 2023 and beyond, says Helena Beer.

A postcode can determine health outcomes more than genetics. How can pharma help to solve the postcode lottery?

Pharma endeavours to drive positive action from patient insights. Read to find out how they could improve their methodologies and outcomes.

RWD for rare diseases is scarce, but pharma can work to leverage existing processes and build trust to enhance the scope of available data.

Generics and biosimilars are crucial to healthcare worldwide, but there are challenges in getting these medicine to patients.

The challenges faced by the transgender community are vast, but pharma has the power to drive better health equity. Read more.

With Moderna pledging not to enforce its COVID-19 vaccine patent in 92 LMICs, a hub in South Africa is pushing ahead with replication. Read for more details.

The pandemic has exacerbated already troubling trends in the market access but has also created an opportunity for change in how drugs are priced and procured.

Pharma is making great strides in tackling climate change, but more needs to be done to meet net zero targets.

Why is the purpose and value of medical affairs sometimes poorly understood by the wider pharma organisation, and what can be done?

In his second column, Davidek Herron, Global Head of Digital, Roche, considers this year’s successes and challenges and looks ahead to 2023.

While technology advances and mindsets shift, will there be space and demand for the role of the pharma sales reps in future?

The Japanese pharma industry has many intricacies, so how can companies navigate the ups and downs?

Daiichi Sankyo’s Mary Pinder-Schenck speaks about the evolution she has witnessed in oncology throughout her career and what she predicts for the future of the field.

A new review has outlined 20 recommendations for how the UK can become a world leader in cannabinoid innovation. But is it possible?

The pharmaceutical industry has been trying to refine, reduce and replace animal testing for some time, but animal rights activists argue progress is too incremental.

The overturning of Roe v. Wade is impacting access to medical abortion, but in what ways is pharma trying to help?

Two US pricing experts dissect the implications of The Inflation Reduction for the pharma industry in this roundtable.